P566 Maintenance vedolizumab treatment in pediatric IBD: 54-week follow-up of the prospective multicenter VEDOKIDS study
Atia, O, Shavit-Brunschwig, Z, Focht, G, Lev-Tzion, R, Stein, R, Broide, E, Urlep, D, Hyams, J, Weiss, B, Aloi, M, Assa, A, Russell, R K, Turner, D
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
P774 Maintenance treatment with vedolizumab in children with Inflammatory Bowel Disease: follow-up results from the prospective multicenter VEDOKIDS study
Atia, O, Shavit-Brunschwig, Z, Quteineh, A, Lev-Tzion, R, Stein, R, Broide, E, Urlep, D, Hyams, J, Aloi, M, Shouval, D S, Assa, A, Hussey, S, Markowitz, J, Yerushalmy, A, Miele, E, Russell, R K, Turner, D
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P538 Vedolizumab is effective in real life paediatric inflammatory bowel disease: report from the prospective, multi-centre VEDOKIDS cohort study
Shavit-Brunschwig, Z, Ledder, O, Focht, G, Urlep, D, Lev-Tzion, R, Marcus, D, Broide, E, Assa, A, Hussey, S, Yerushalmy-Feler, A, Levine, A, Markowitz, J, Norden, C, Turner, D
Published in Journal of Crohn's and colitis (25.01.2019)
Published in Journal of Crohn's and colitis (25.01.2019)
Get full text
Journal Article